InvestorsHub Logo
Followers 17
Posts 1103
Boards Moderated 0
Alias Born 04/07/2020

Re: None

Monday, 03/01/2021 4:41:01 PM

Monday, March 01, 2021 4:41:01 PM

Post# of 232880
CD12 still recruiting, only with OLE, no plecebo, Leronlimab for every patient. FDA has CD12 data, they must like what they see otherwise OLE would be revoked and the trial stopped.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News